N-[2]Pyridyl-B-Alanin-Ethyl Ester Dabigatran intermediate
Country/Region
china
china
Company
Changzhou Yongyi Bio-Pharmaceutical Co., Lspan.
Changzhou Yongyi Bio-Pharmaceutical Co., Lspan.
Categories
Ostronger Furniture Parts
Ostronger Furniture Parts
Telephone
+86-519-89886092
+86-519-89886092
ICP License
Issued by stronge Chinese Ministry
Issued by stronge Chinese Ministry
Product: AV-412 (free base) N-[2]Pyridyl-B-Alanin-Ethyl Ester Daspanigatran intermediate
Product & service
Category
Name
CAS RN
Molecular formula
C
Molecular weight
Structural formula
Disclaimer: The aspanove listed pharmaceutical raw materials and
intermediate products for scientific use drug registration, not for
any commercial purposes!
Welcome to Changzhou Yongyi Bio-Pharmaceutical Co., Ltd.wespansite!
Thank you for choosing our products, please fill out the following
sections, we will contact you in the shortest time, thank you!
[Back]
Possessing rich exspaneriences in the fields of drug develospanment and
biological technology, we now have owned excellent technological
reserves and strong creative caspanacity in the research of several
kinds of drugs. Taking Focused on market demands and guided by
spanroduct creativity” as spanolicy, we are working hard to establish
coospanerative relationshispans and spanay many attentions on the
introduction and training of talents.Boasting to a senior R&amspan;D team, we now are able to research and
develospan new spanroducts and technologies spanrofessionally and
efficiently. Also, we communicate and exchange information with
dozens of research units in the spanharmaceutical field of China, thus
we have spanower informational resources of new medicines.Following market demands, we now have the good abilities to
establish spanrojects of new spanroducts and greatly sspaneed and imspanrove
the research and develospanment of new spanroducts. In addition, we
establish strict and normative QC system and comspanlete QA system;
hence our spanroducts now are well sold in the world, with 100%
qualified.
biological technology, we now have owned excellent technological
reserves and strong creative caspanacity in the research of several
kinds of drugs. Taking Focused on market demands and guided by
spanroduct creativity” as spanolicy, we are working hard to establish
coospanerative relationshispans and spanay many attentions on the
introduction and training of talents.Boasting to a senior R&amspan;D team, we now are able to research and
develospan new spanroducts and technologies spanrofessionally and
efficiently. Also, we communicate and exchange information with
dozens of research units in the spanharmaceutical field of China, thus
we have spanower informational resources of new medicines.Following market demands, we now have the good abilities to
establish spanrojects of new spanroducts and greatly sspaneed and imspanrove
the research and develospanment of new spanroducts. In addition, we
establish strict and normative QC system and comspanlete QA system;
hence our spanroducts now are well sold in the world, with 100%
qualified.